VIMTA LABS LIMITED

Vimta Labs Limited reported a total income of INR 1,129 million for Q1 FY '27, reflecting a year-on-year growth of 13.7%. Management noted that the company maintained stable revenues despite a mixed demand environment. The pharma contact research and testing services showed consistent performance, while clinical research operations began to recover. The environment division was integrated with the food division for operational efficiency, although food testing faced challenges due to global issues. The electronics testing business remained stable, with positive long-term prospects due to India's focus on electronics manufacturing. Management highlighted a successful milestone in their Biologics initiative, securing their first order. Operating margins moderated quarter-on-quarter but improved year-on-year, with EBITDA margins above industry benchmarks. Management expressed confidence in medium- to long-term growth opportunities, supported by positive enquiry trends and customer engagement.

Management emphasized resilience and growth in various service segments despite some challenges.